BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,282,898 | -30.6% | 325,461 | -16.2% | 0.02% | -25.0% |
| Q2 2023 | $17,704,343 | -35.1% | 388,594 | -42.2% | 0.02% | -39.4% |
| Q1 2023 | $27,272,422 | -17.5% | 672,397 | +3.6% | 0.03% | -19.5% |
| Q4 2022 | $33,073,465 | +30.5% | 648,881 | +41.6% | 0.04% | +28.1% |
| Q3 2022 | $25,343,000 | -0.2% | 458,288 | +15.9% | 0.03% | +10.3% |
| Q2 2022 | $25,398,000 | +32.5% | 395,419 | +60.0% | 0.03% | +61.1% |
| Q1 2022 | $19,166,000 | -3.6% | 247,177 | +6.7% | 0.02% | +5.9% |
| Q4 2021 | $19,890,000 | +21.6% | 231,708 | +13.9% | 0.02% | 0.0% |
| Q3 2021 | $16,362,000 | +2.0% | 203,439 | -1.9% | 0.02% | +6.2% |
| Q2 2021 | $16,042,000 | -5.4% | 207,397 | +3.2% | 0.02% | -15.8% |
| Q1 2021 | $16,953,000 | +4.9% | 201,005 | -0.2% | 0.02% | -5.0% |
| Q4 2020 | $16,168,000 | -0.1% | 201,500 | +0.1% | 0.02% | -9.1% |
| Q3 2020 | $16,188,000 | +35.6% | 201,289 | +45.2% | 0.02% | +29.4% |
| Q2 2020 | $11,939,000 | +2.7% | 138,662 | -3.1% | 0.02% | -15.0% |
| Q1 2020 | $11,621,000 | -1.0% | 143,130 | +2.0% | 0.02% | +17.6% |
| Q4 2019 | $11,738,000 | -15.4% | 140,366 | -11.5% | 0.02% | -19.0% |
| Q3 2019 | $13,877,000 | +6.0% | 158,649 | -0.7% | 0.02% | +5.0% |
| Q2 2019 | $13,089,000 | -3.7% | 159,818 | -4.4% | 0.02% | -4.8% |
| Q1 2019 | $13,593,000 | +17.9% | 167,172 | -4.6% | 0.02% | +5.0% |
| Q4 2018 | $11,529,000 | -14.6% | 175,160 | -0.0% | 0.02% | 0.0% |
| Q3 2018 | $13,507,000 | +10.5% | 175,212 | +5.8% | 0.02% | +5.3% |
| Q2 2018 | $12,226,000 | -15.9% | 165,568 | -25.9% | 0.02% | -13.6% |
| Q1 2018 | $14,534,000 | -12.5% | 223,467 | -13.1% | 0.02% | -8.3% |
| Q4 2017 | $16,618,000 | -9.2% | 257,079 | -11.8% | 0.02% | -11.1% |
| Q3 2017 | $18,296,000 | -15.2% | 291,566 | -18.2% | 0.03% | -20.6% |
| Q2 2017 | $21,567,000 | +15.0% | 356,240 | -1.5% | 0.03% | +13.3% |
| Q1 2017 | $18,750,000 | +1.2% | 361,535 | -13.4% | 0.03% | -3.2% |
| Q4 2016 | $18,520,000 | -18.5% | 417,691 | -12.5% | 0.03% | -20.5% |
| Q3 2016 | $22,735,000 | -3.0% | 477,629 | -7.8% | 0.04% | -7.1% |
| Q2 2016 | $23,430,000 | +0.4% | 518,134 | -8.8% | 0.04% | -4.5% |
| Q1 2016 | $23,338,000 | +1.6% | 568,112 | -5.6% | 0.04% | -4.3% |
| Q4 2015 | $22,966,000 | -0.6% | 601,995 | -14.4% | 0.05% | +2.2% |
| Q3 2015 | $23,100,000 | -60.1% | 703,215 | -15.2% | 0.04% | -56.7% |
| Q2 2015 | $57,967,000 | +21.6% | 828,922 | +19.1% | 0.10% | +20.9% |
| Q1 2015 | $47,684,000 | -24.0% | 696,123 | -18.7% | 0.09% | -18.1% |
| Q4 2014 | $62,755,000 | +40.3% | 856,263 | +37.4% | 0.10% | +36.4% |
| Q3 2014 | $44,716,000 | +44.4% | 623,036 | +45.5% | 0.08% | +45.3% |
| Q2 2014 | $30,965,000 | +0.7% | 428,287 | +2.5% | 0.05% | -5.4% |
| Q1 2014 | $30,748,000 | +10.5% | 417,881 | +4.5% | 0.06% | +7.7% |
| Q4 2013 | $27,817,000 | +12.4% | 399,956 | +6.2% | 0.05% | +6.1% |
| Q3 2013 | $24,739,000 | -16.8% | 376,601 | -12.3% | 0.05% | -23.4% |
| Q2 2013 | $29,749,000 | – | 429,466 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |